Latest Society for Maternal-Fetal Medicine Stories
PRINCETON, N.J., Feb. 14, 2013 /PRNewswire/ -- PeriGen, Inc., the global leader in applying real-time clinical decision support to perinatal systems, announced today that it has appointed Thomas J.Garite MD as Chief Clinical Officer, effective immediately. (Logo: http://photos.prnewswire.com/prnh/20110512/PH01144LOGO ) A specialist in Obstetrics and Gynecology and Maternal-Fetal Medicine, in addition to his work with PeriGen and its clients, Thomas J. Garite, MD, holds three...
March of Dimes Award Abstract at SMFM Meeting SAN FRANCISCO, Feb. 14, 2013 /PRNewswire-USNewswire/ -- In a study to be presented today at the Society for Maternal-Fetal Medicine's 33(rd) annual meeting, The Pregnancy Meeting(TM), researchers will report findings that suggest that 17P, a form of progesterone, is not effective in preventing preterm birth among women with twin pregnancies -- and may possibly be harmful. (Logo: http://photos.prnewswire.com/prnh/20130214/DC59689LOGO)...
In a study to be presented on February 16 between 8 a.m., and 10 a.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting ™, in San Francisco, researchers will report findings that suggest shifting from a traditional model of obstetrical care to a laborist model improves pregnancy outcomes. The "laborist" concept has been around for nearly a decade. In this model, obstetricians provide 24-hour a day on-site staffing of labor units. While it has been...
In a study to be presented on February 14 between 1:15 p.m., and 3:30 p.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting ™, in San Francisco, California, researchers will present data showing changes in elective delivery policy have been successful in reducing elective deliveries prior to 39 weeks. Due to the troubling trend of elective delivery and induction, significant attention has been paid to the neonatal benefits of reducing elective...
SAN DIEGO, Nov. 21, 2012 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced that the American College of Obstetricians and Gynecologists (ACOG) Committee on Genetics and the Society for Maternal-Fetal Medicine (SMFM) Publications Committee issued a joint Committee Opinion on November 20, 2012, recommending that cell-free fetal DNA testing be offered to patients at increased risk...
PRINCETON, N.J., Aug. 15, 2012 /PRNewswire/ -- PeriGen, Inc., an innovative, national provider of fetal surveillance systems, today announced the publication of research on uterine tachysystole in the June issue of the Journal of Maternal-Fetal and Neonatal Medicine, which showed that high contraction rates were common in deliveries with normal blood gases at birth. The study revealed that fetal heart rate decelerations, in response to any level of contractions, and especially...
HOUSTON, March 27, 2012 /PRNewswire/ -- Texas Children's Hospital announced the start of labor and delivery services and the arrival of its first baby, a healthy boy, at its landmark new facility, Texas Children's Pavilion for Women. The nationally-ranked children's hospital has now fully expanded into obstetrical and gynecological care with the completion of its 15-story, $575-million state-of-the-art hospital which is staffed, designed and equipped to be among the nation's...
Length of residence increases risk The longer a Hispanic woman lives in the United States, the higher her risk of preterm birth (PTB), with nearly half of PTBs among Hispanic women occurring in those who were born in the U.S. This is the main finding of a study by researchers at the University of Texas Medical Branch (UTMB) at Galveston who sought to shed light on possible environmental factors in PTB. It is one of several studies from UTMB presented this week at the Society for...
In a study to be presented today at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting ™, in Dallas, Texas, researchers will report findings that indicate that elevated levels of cell-free DNA in the first trimester do not predict the subsequent development of preeclampsia. "I wanted to identify if elevated levels of cell-free fetal DNA in maternal blood early in pregnancy could identify women at risk for the subsequent development of preeclampsia. I found...
In a study to be presented today at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting ™, in Dallas, Texas, researchers will report findings that show that short therapy with the anti-diabetic medication Pioglitazone can prevent the long term effects of maternal obesity on offspring. This study, Pioglitazone Therapy in Offspring Exposed to Maternal Obesity, is the first step in the long term goal of preventing metabolic syndrome and obesity in children...
